The Hindu·3 min read·medium
Sun Pharma gets Brazil nod for Semaglutide
N
N. Ravi Kumar
✦AI Summary
Sun Pharma has received regulatory approval in Brazil to manufacture and market generic semaglutide for type 2 diabetes. This expansion follows the company's recent launch of the drug in South Africa and India.
Sun Pharmaceutical Industries has received Brazilian Health Regulatory Agency ANVISA approval to manufacture and market semaglutide injection in the Latin American country.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in